Cargando…
The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467556/ https://www.ncbi.nlm.nih.gov/pubmed/30789452 http://dx.doi.org/10.1097/QAI.0000000000001986 |
_version_ | 1783411285304541184 |
---|---|
author | Rossetti, Barbara Gagliardini, Roberta Sterrantino, Gaetana Colangeli, Vincenzo Latini, Alessandra Colafigli, Manuela Vignale, Francesca Rusconi, Stefano Di Biagio, Antonio Orofino, Giancarlo Mezzaroma, Ivano Vullo, Vincenzo Francisci, Daniela Mastroianni, Claudio Trezzi, Michele Canovari, Benedetta Lamonica, Silvia Ciccullo, Arturo Borghetti, Alberto D'Arminio Monforte, Antonella Di Giambenedetto, Simona De Luca, Andrea |
author_facet | Rossetti, Barbara Gagliardini, Roberta Sterrantino, Gaetana Colangeli, Vincenzo Latini, Alessandra Colafigli, Manuela Vignale, Francesca Rusconi, Stefano Di Biagio, Antonio Orofino, Giancarlo Mezzaroma, Ivano Vullo, Vincenzo Francisci, Daniela Mastroianni, Claudio Trezzi, Michele Canovari, Benedetta Lamonica, Silvia Ciccullo, Arturo Borghetti, Alberto D'Arminio Monforte, Antonella Di Giambenedetto, Simona De Luca, Andrea |
author_sort | Rossetti, Barbara |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6467556 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | JAIDS Journal of Acquired Immune Deficiency Syndromes |
record_format | MEDLINE/PubMed |
spelling | pubmed-64675562019-05-29 The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study Rossetti, Barbara Gagliardini, Roberta Sterrantino, Gaetana Colangeli, Vincenzo Latini, Alessandra Colafigli, Manuela Vignale, Francesca Rusconi, Stefano Di Biagio, Antonio Orofino, Giancarlo Mezzaroma, Ivano Vullo, Vincenzo Francisci, Daniela Mastroianni, Claudio Trezzi, Michele Canovari, Benedetta Lamonica, Silvia Ciccullo, Arturo Borghetti, Alberto D'Arminio Monforte, Antonella Di Giambenedetto, Simona De Luca, Andrea J Acquir Immune Defic Syndr Letters to the Editor JAIDS Journal of Acquired Immune Deficiency Syndromes 2019-05-01 2019-02-13 /pmc/articles/PMC6467556/ /pubmed/30789452 http://dx.doi.org/10.1097/QAI.0000000000001986 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Letters to the Editor Rossetti, Barbara Gagliardini, Roberta Sterrantino, Gaetana Colangeli, Vincenzo Latini, Alessandra Colafigli, Manuela Vignale, Francesca Rusconi, Stefano Di Biagio, Antonio Orofino, Giancarlo Mezzaroma, Ivano Vullo, Vincenzo Francisci, Daniela Mastroianni, Claudio Trezzi, Michele Canovari, Benedetta Lamonica, Silvia Ciccullo, Arturo Borghetti, Alberto D'Arminio Monforte, Antonella Di Giambenedetto, Simona De Luca, Andrea The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study |
title | The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study |
title_full | The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study |
title_fullStr | The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study |
title_full_unstemmed | The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study |
title_short | The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study |
title_sort | effect of switching to maraviroc + darunavir/ritonavir dual therapy in virologically suppressed patients on the progression of liver fibrosis: findings from a randomized study |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467556/ https://www.ncbi.nlm.nih.gov/pubmed/30789452 http://dx.doi.org/10.1097/QAI.0000000000001986 |
work_keys_str_mv | AT rossettibarbara theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT gagliardiniroberta theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT sterrantinogaetana theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT colangelivincenzo theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT latinialessandra theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT colafiglimanuela theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT vignalefrancesca theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT rusconistefano theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT dibiagioantonio theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT orofinogiancarlo theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT mezzaromaivano theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT vullovincenzo theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT franciscidaniela theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT mastroianniclaudio theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT trezzimichele theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT canovaribenedetta theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT lamonicasilvia theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT cicculloarturo theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT borghettialberto theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT darminiomonforteantonella theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT digiambenedettosimona theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT delucaandrea theeffectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT rossettibarbara effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT gagliardiniroberta effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT sterrantinogaetana effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT colangelivincenzo effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT latinialessandra effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT colafiglimanuela effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT vignalefrancesca effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT rusconistefano effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT dibiagioantonio effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT orofinogiancarlo effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT mezzaromaivano effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT vullovincenzo effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT franciscidaniela effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT mastroianniclaudio effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT trezzimichele effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT canovaribenedetta effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT lamonicasilvia effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT cicculloarturo effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT borghettialberto effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT darminiomonforteantonella effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT digiambenedettosimona effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy AT delucaandrea effectofswitchingtomaravirocdarunavirritonavirdualtherapyinvirologicallysuppressedpatientsontheprogressionofliverfibrosisfindingsfromarandomizedstudy |